Indivior Share News (INDV)

IN BRIEF: Indivior settles patent infringement case with DRL

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Enters into a settlement agreement with Indian pharmaceutical company Dr Reddy's Laboratories Ltd and its subsidiaries together with Aquestive Therapeutics Inc. Explains that the settlement is for a patent infringement case regarding DRL's generic buprenorphine and naloxone sublingual film that is equivalent to its Suboxone sublingual film.

Indivior settles patent litigation with Dr. Reddy's

(Sharecast News) - Opioid addiction treatment maker Indivior has settled a patent infringement case with generic drug maker Dr. Reddy's Laboratories.

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Indivior commences USD100 million share buyback programme

(Alliance News) - Indivior PLC on Tuesday said it has commenced a share buyback programme for up to USD100 million, signing a non-discretionary agreement with Stifel Nicolaus Europe Ltd in relation to the programme.

UK shareholder meetings calendar - next 7 days

Indivior set to meet full-year guidance; announces buyback

(Alliance News) - Indivior PLC said on Thursday its strong start to 2022 had put it on track to meet its annual guidance as the company also announced a new USD100 million buyback.

Indivior maintains guidance after 'strong start' to year

(Sharecast News) - Pharmaceuticals firm Indivior reported first quarter net revenue of $207m (£165.07m) in an update on Thursday, up 15% year-on-year, as it maintained its guidance for the full year.

LONDON BROKER RATINGS: Barclays downgrades Aviva and raises Just Group

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Indivior starts formal shareholder talks over additional US listing

(Sharecast News) - Opioid addiction treatment maker Indivior said on Thursday that it is beginning formal consultations with shareholders about a potential additional listing of its shares in the US.

LONDON BROKER RATINGS: Next and B&M raised; British Land cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

LONDON BRIEFING: Petropavlovsk warns bank sanctions to hit gold sales

(Alliance News) - Russian gold miner Petropavlovsk on Friday warned it has a USD200 million term loan and a USD86.7 million revolving credit facility with Gazprombank, a bank which now has been sanctioned by the UK, in the wake of Russia's invasion of Ukraine.

DIRECTOR DEALINGS: Indivior chief HR officer sells; Volex COO buys

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

IN BRIEF: Indivior strategy chief Simkin sells GBP800,000 in shares

Indivior PLC - North Chesterfield, Virginia-based treatments for opioid addiction - Chief Commercial & Strategy Officer Richard Simkin sells 300,000 shares at GBP2.70, worth GBP810,000, on Thursday. The sale represented just under half of his Indivior shareholding, retaining 340,025 shares. Indivior on Wednesday had reported a swing to profit in 2021 and said it is considering a US share listing.

LONDON MARKET CLOSE: Stocks edge lower on doubts over Russia pullback

(Alliance News) - Stocks in London on Wednesday ended on a subdued note amid doubts over the reported pullback of Russian forces from the Ukraine borders.

LONDON MARKET MIDDAY: Stocks struggle as NATO doubts Russia withdrawal

(Alliance News) - European equities were mixed midday Wednesday as a tense situation on the Ukraine border and a staggering UK inflation figure saw trepidation creep in, with markets surrendering earlier gains.